Suchergebnisse - "Hong, Fangxin"

PubPharm (16)

1

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Nowakowski, G. | Hong, F. | Scott, D. | +18

CommentIn: J Clin Oncol. 2021 Apr 20;39(12):1314-1316. - PMID 33621123

2

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols : An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis

enthalten in: Cancer | 2018

von Henderson, T. | Parsons, S. | Wroblewski, K. | +20

3

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

enthalten in: British journal of haematology | 2015

von Diefenbach, C. | Li, H. | Hong, F. | +17

CommentIn: Br J Haematol. 2017 Jul;178(2):336-338. - PMID 27135208

4

A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma : ECOG3402

enthalten in: British journal of haematology | 2015

von Witzig, T. | Hong, F. | Micallef, I. | +6

5

Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning : ECOG-ACRIN Cancer Research Group study (E3404)

enthalten in: British journal of haematology | 2015

von Swinnen, L. | Li, H. | Quon, A. | +7

6

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma : A Subset Analysis of the North American Intergroup E2496 Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2015

von Advani, R. | Hong, F. | Fisher, R. | +15

7

Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms : an Eastern Cooperative Oncology Group study (E2404)

enthalten in: Leukemia & lymphoma | 2014

von Ganjoo, K. | Hong, F. | Horning, S. | +6

CommentIn: Leuk Lymphoma. 2014 Apr;55(4):727-9. - PMID 24295133

8

Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma : correlative analysis from a large North American cooperative group trial

enthalten in: Blood | 2013

von Kanakry, J. | Li, H. | Gellert, L. | +15

CommentIn: Blood. 2013 May 2;121(18):3541-2. - PMID 23640993

9

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients : a comprehensive analysis from the North American intergroup trial E2496

enthalten in: British journal of haematology | 2013

von Evens, A. | Hong, F. | Gordon, L. | +13

10

How can outcomes be improved for older patients with Hodgkin lymphoma?

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2013

von Evens, A. | Hong, F.

CommentOn: J Clin Oncol. 2013 Apr 20;31(12):1522-9. - PMID 23509310